Inimmune
Phase 2Harnessing the Immune System to Improve Human Health Our Pipeline Our Pipeline Harnessing the Immune System to Improve Human Health Our Pipeline Our Pipeline July 24, 2024 July 16, 2024 May 15, 2024 January 8, 2024 December 1, 2023 November 30, 2023 July 24, 2024 July 16, 2024 May 15, 2024 January 8, 2024 December
Founded
2016
Focus
Small Molecules
About
Harnessing the Immune System to Improve Human Health Our Pipeline Our Pipeline Harnessing the Immune System to Improve Human Health Our Pipeline Our Pipeline July 24, 2024 July 16, 2024 May 15, 2024 January 8, 2024 December 1, 2023 November 30, 2023 July 24, 2024 July 16, 2024 May 15, 2024 January 8, 2024 December
Funding History
3Total raised: $62.5M
Grant$2.5MNational Institutes of Health (NIH)Mar 15, 2021
Series B$40MRiverVest Venture PartnersOct 15, 2020
Series A$20MTwo River GroupMay 15, 2018
Company Info
TypePrivate
Founded2016
LocationMissoula, United States
StagePhase 2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile